Patents by Inventor Joseph M. Palumbo

Joseph M. Palumbo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210177830
    Abstract: The present disclosure is directed to compositions and methods for treating or preventing vasomotor symptoms such as hot flashes, comprising a Transient Receptor Potential Melastatin 8 (TRPM8) antagonist and administering a TRPM8 antagonist, respectively.
    Type: Application
    Filed: February 27, 2021
    Publication date: June 17, 2021
    Inventor: Joseph M. Palumbo
  • Patent number: 10993939
    Abstract: The present disclosure is directed to compositions and methods for treating or preventing vasomotor symptoms such as hot flashes, comprising a Transient Receptor Potential Melastatin 8 (TRPM8) antagonist and administering a TRPM8 antagonist, respectively.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: May 4, 2021
    Assignee: Mitsubishi Tanabe Pharmaceutical Company
    Inventor: Joseph M. Palumbo
  • Publication number: 20200383968
    Abstract: The present disclosure is directed to compositions comprising as an active ingredient, a lower dose of 4-({(1-cyclopropy-lisoquinolm-3-yl)[4-(trifluoromethoxy)benzyl]amino}sulfonyl)benzoic acid or a pharmaceutically acceptable salt thereof for treating or preventing vasomotor symptoms in a subject, and methods which comprises administering the said compound or the pharmaceutically acceptable salt thereof at a lower dose, respectively.
    Type: Application
    Filed: December 18, 2018
    Publication date: December 10, 2020
    Applicant: Mitsubishi Tanabe Pharma Corporation
    Inventor: Joseph M. PALUMBO
  • Publication number: 20200190182
    Abstract: Based on the identification of IL-33 as an exacerbating factor in endometriosis and adenomyosis uteri, a therapeutic agent for endometriosis and adenomyosis uteri has an IL-33 antagonist, which is capable of inhibiting the function of IL-33. The IL-33 antagonist is useful for treating, preventing or alleviating endometriosis and uterine adenomyosis uteri.
    Type: Application
    Filed: August 31, 2018
    Publication date: June 18, 2020
    Inventors: Tomohiro YOSHIMOTO, Joseph M. PALUMBO, Violetta I. STONE, Torn KATO, Koubun YASUDA
  • Publication number: 20190142821
    Abstract: The present disclosure is directed to compositions and methods for treating or preventing vasomotor symptoms such as hot flashes, comprising a Transient Receptor Potential Melastatin 8 (TRPM8) antagonist and administering a TRPM8 antagonist, respectively.
    Type: Application
    Filed: June 12, 2017
    Publication date: May 16, 2019
    Inventor: Joseph M. Palumbo
  • Publication number: 20070232624
    Abstract: The present invention provides a pharmaceutical composition, and provides for the use thereof for the treatment of excessive daytime sleepiness and/or a sleep disturbance in a psychiatric patient in need thereof. The pharmaceutical composition comprises a therapeutically effective amount of paliperidone, its pharmaceutically acceptable acid addition salts, enantiomeric forms, and esters thereof, together with a pharmaceutical carrier, and provides a relatively low plasma concentration variation of paliperidone to the psychiatric patient in need of treatment. The present invention also provides for the use of a pharmaceutical composition as defined above, in the preparation of a medicament for the treatment of excessive daytime sleepiness and/or a sleep disturbance in a psychiatric patient in need thereof.
    Type: Application
    Filed: September 22, 2006
    Publication date: October 4, 2007
    Inventors: Joseph M. Palumbo, Marie-Henriette Eerdekens, Michelle Kramer